信息搜索
信息关键字：药
  

共有5342条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263] [264] [265] [266] [267] [268]

·屡败屡战，屡战屡败天目药业第7次重组又“黄”了2018-1-2 23:42:04
·安科生物参股公司CAR-T疗法获药品注册申请受理2018-1-2 21:18:26
·月度机构调研动向：亿帆医药被147家机构扎堆调研2018-1-2 15:35:08
·利欣制药曾两度被纳为失信被执行人2018-1-2 15:10:10
·资金未到位龙发制药股票发行认购缴款延后两月2018-1-2 15:02:01
·天目药业：控股股东现在、将来都不会出让控制权2018-1-2 14:11:08
·安科生物参股公司获得药品注册申请受理2018-1-2 13:37:42
·安科生物：参股公司肿瘤治疗临床试验申请获食药监总局受理2018-1-2 13:00:03
·安科生物：参股公司肿瘤治疗临床试验申请获食药监总局受理2018-1-2 12:35:09
·医药生物行业：关注一致性评价后续品种投资机会2018-1-2 11:20:02
·陷“行贿门”产品质量亮红灯步长制药由“最贵新股”沦为“绞肉机”2018-1-2 11:19:57
·医药生物行业：关注一致性评价后续品种投资机会2018-1-2 11:15:38
·2018年医药迎来慢牛行情首推一致性评价标的2018-1-2 11:07:32
·2018年医药迎来慢牛行情首推一致性评价标的2018-1-2 10:58:55
·亿源药业GMP证书被收回主办券商提示风险2018-1-2 10:09:40
·医药市场格局加速重塑4家公司产品首批通过一致性评价2018-1-2 8:24:43
·天目药业第七次重组终止2018-1-2 4:18:26
·产品质量亮红灯步长制药由最贵新股沦为“绞肉机”2018-1-2 1:33:44
·信邦制药：控股股东一致行动人近日增持2006万股2018-1-1 18:44:44
·福瑞股份：拟收购关联方医药制造资产继续停牌2018-1-1 17:25:25

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263] [264] [265] [266] [267] [268]